On April 13, the Senate Aging Committee is holding a hearing entitled “A Delicate Balance: FDA and the Reform of the Medical Device Approval Process.”  In addition, the House Oversight and Government Reform Health Care Subcommittee is holding a hearing April 14 on “Pathway To FDA Medical Device Approval: Is There A Better Way?.”

Separately, on April 13, the House Energy and Commerce Subcommittee on Oversight and Investigations has scheduled a hearing on “Import Safety: Status of FDA’s Screening Efforts at the Border.”  On April 14, the Subcommittee on Commerce, Manufacturing, and Trade is holding a hearing on “Warning: The Growing Danger of Prescription Drug Diversion.”